Figure 4: The function curve with values of the logs of odds ratios from the GAM model with splines regarding MRA for our multilevel discrete-time event history analysis of risk of death among PA patients. | Scientific Reports

Figure 4: The function curve with values of the logs of odds ratios from the GAM model with splines regarding MRA for our multilevel discrete-time event history analysis of risk of death among PA patients.

From: Long term outcome of Aldosteronism after target treatments

Figure 4

The curve was centered to have an average of zero over the range of the data. The dashed lines indicated approximated point-wise 95% CIs. (Abbreviations: CI, confidence interval; DDD, defined daily dose; GAM, generalized additive model; MRA, mineralocorticoid receptor antagonist; PA, primary aldosteronism) (The DDD of MRA is 0.17 (12.5 mg of spironolactone) and 0.66 (50 mg spironolactone).

Back to article page